Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

6.39
Delayed Data
As of Feb 05
 -0.35 / -5.19%
Today’s Change
4.05
Today|||52-Week Range
11.26
-38.38%
Year-to-Date

Today’s Trading

Previous close6.74
Today’s open6.74
Day’s range6.38 - 6.74
Volume2,150,141
Average volume (3 months)2,116,649
Market cap$1.2B
Dividend yield--
Data as of 4:01pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-63.64%
Earnings growth (this year)--
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+71.23%
P/E ratioNM
Price/Sales44.34
Price/Book20.61

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...-4.01-12.30%
IRWDIronwood Pharmaceuti...-0.65-7.16%
PBYIPuma Biotechnology I...-4.26-9.69%
INSYINSYS Therapeutics I...-0.27-1.63%
Data as of 4:01pm ET, 02/05/2016

Financials

Next reporting dateMarch 8, 2016
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$15.0M
Annual profit (last year)-$54.2M
Net profit margin-360.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President, Secretary &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts

Partner Offers